{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:58:57Z","timestamp":1781060337163,"version":"3.54.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["CA151692"],"award-info":[{"award-number":["CA151692"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Chemotherapy-induced peripheral neuropathy (CIPN) is associated with a large amount of interindividual variability in signs and symptoms. The purposes were to use latent profile analysis to identify subgroups of survivors with distinct lower extremity (LE) loss-of-function CIPN profiles; evaluate for differences in demographic, clinical, and pain characteristics between the profiles and characteristics associated with membership in the more severe profile; and examine relationships between the profiles and measures of large fiber loss and C-tactile fiber function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>LE loss-of-function CIPN profiles were created using measures of worst pain, loss of light touch sensation, loss of cold sensation, loss of pain sensation, vibration threshold, and two balance measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 405 survivors evaluated, two distinct profiles were identified: less severe loss of LE function (76.5%) and more severe loss of LE function (23.5%). Risk factors for membership in the more severe profile included being older, male, and having lower functional status. In terms of the loss of large fiber function, survivors in the more severe class had four more sites on average that lost light touch sensation; their vibration thresholds were 1.5 times higher; and their ratings of numbness were significantly higher. For C-tactile fiber function, significant between-group differences were found in survivors\u2019 ratings of the severity of sensitive skin and unpleasantness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings suggest that distinct \u201cCIPN phenotypes\u201d can be identified in cancer survivors. Detailed phenotyping and molecular characterization of various CIPN phenotypes will lead to the development and testing of targeted and personalized interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-10736-5","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:02:18Z","timestamp":1778155338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Large fiber contribution to symptoms in chemotherapy-induced peripheral neuropathy in cancer survivors"],"prefix":"10.1007","volume":"34","author":[{"given":"Jon D.","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette P.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn J.","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Miaskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"7","key":"10736_CR1","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.clinph.2017.04.009","volume":"128","author":"T Kandula","year":"2017","unstructured":"Kandula T, Farrar MA, Kiernan MC, Krishnan AV, Goldstein D, Horvath L et al (2017) Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer. Clin Neurophysiol 128(7):1166\u201375. https:\/\/doi.org\/10.1016\/j.clinph.2017.04.009","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"10736_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2015.11.011","volume":"140","author":"JR Brewer","year":"2016","unstructured":"Brewer JR, Morrison G, Dolan ME, Fleming GF (2016) Chemotherapy-induced peripheral neuropathy: current status and progress. Gynecol Oncol 140(1):176\u2013183. https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.011","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10736_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1023\/a:1008345613594","volume":"11","author":"TJ Postma","year":"2000","unstructured":"Postma TJ, Heimans JJ (2000) Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol 11(5):509\u201313. https:\/\/doi.org\/10.1023\/a:1008345613594","journal-title":"Ann Oncol"},{"issue":"6","key":"10736_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1188\/07.CJON.901-913","volume":"11","author":"C Visovsky","year":"2007","unstructured":"Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C (2007) Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 11(6):901\u2013913. https:\/\/doi.org\/10.1188\/07.CJON.901-913","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"10736_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","volume":"13","author":"AJ Windebank","year":"2008","unstructured":"Windebank AJ, Grisold W (2008) Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13(1):27\u201346. https:\/\/doi.org\/10.1111\/j.1529-8027.2008.00156.x","journal-title":"J Peripher Nerv Syst"},{"issue":"11","key":"10736_CR6","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.ejca.2008.04.018","volume":"44","author":"S Wolf","year":"2008","unstructured":"Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C (2008) Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44(11):1507\u201315. https:\/\/doi.org\/10.1016\/j.ejca.2008.04.018","journal-title":"Eur J Cancer"},{"issue":"Suppl 1","key":"10736_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/00023210-200721001-00002","volume":"21","author":"A Vanotti","year":"2007","unstructured":"Vanotti A, Osio M, Mailland E, Nascimbene C, Capiluppi E, Mariani C (2007) Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies. CNS Drugs 21(Suppl 1):3\u201312. https:\/\/doi.org\/10.2165\/00023210-200721001-00002","journal-title":"CNS Drugs"},{"issue":"5","key":"10736_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejpain.2011.03.005","volume":"15","author":"N Attal","year":"2011","unstructured":"Attal N, Bouhassira D, Baron R, Dostrovsky J, Dworkin RH, Finnerup N et al (2011) Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome? Eur J Pain 15(5):441\u20133. https:\/\/doi.org\/10.1016\/j.ejpain.2011.03.005","journal-title":"Eur J Pain"},{"issue":"11","key":"10736_CR9","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.pain.2014.08.021","volume":"155","author":"R Baron","year":"2014","unstructured":"Baron R, Dickenson AH (2014) Neuropathic pain: precise sensory profiling improves treatment and calls for back-translation. Pain 155(11):2215\u20132217. https:\/\/doi.org\/10.1016\/j.pain.2014.08.021","journal-title":"Pain"},{"issue":"11","key":"10736_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S1474-4422(12)70189-8","volume":"11","author":"R Baron","year":"2012","unstructured":"Baron R, Forster M, Binder A (2012) Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol 11(11):999\u20131005. https:\/\/doi.org\/10.1016\/S1474-4422(12)70189-8","journal-title":"Lancet Neurol"},{"issue":"2","key":"10736_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/j.pain.0000000000000753","volume":"158","author":"R Baron","year":"2017","unstructured":"Baron R, Maier C, Attal N, Binder A, Bouhassira D, Cruccu G et al (2017) Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain 158(2):261\u201372. https:\/\/doi.org\/10.1097\/j.pain.0000000000000753","journal-title":"Pain"},{"issue":"2","key":"10736_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.pain.2013.10.023","volume":"155","author":"R Freeman","year":"2014","unstructured":"Freeman R, Baron R, Bouhassira D, Cabrera J, Emir B (2014) Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Pain 155(2):367\u201376. https:\/\/doi.org\/10.1016\/j.pain.2013.10.023","journal-title":"Pain"},{"issue":"2","key":"10736_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.pain.2008.01.006","volume":"138","author":"N Attal","year":"2008","unstructured":"Attal N, Fermanian C, Fermanian J, Lanteri-Minet M, Alchaar H, Bouhassira D (2008) Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 138(2):343\u201353. https:\/\/doi.org\/10.1016\/j.pain.2008.01.006","journal-title":"Pain"},{"key":"10736_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/b978-0-444-64032-1.00014-x","volume":"160","author":"J Tavee","year":"2019","unstructured":"Tavee J (2019) Nerve conduction studies: basic concepts. Handb Clin Neurol 160:217\u2013224. https:\/\/doi.org\/10.1016\/b978-0-444-64032-1.00014-x","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10736_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.neuron.2007.07.016","volume":"55","author":"CJ Woolf","year":"2007","unstructured":"Woolf CJ, Ma Q (2007) Nociceptors--noxious stimulus detectors. Neuron 55(3):353\u2013364. https:\/\/doi.org\/10.1016\/j.neuron.2007.07.016","journal-title":"Neuron"},{"key":"10736_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep06370","volume":"4","author":"W Boehmerle","year":"2014","unstructured":"Boehmerle W, Huehnchen P, Peruzzaro S, Balkaya M, Endres M (2014) Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl\/6 mice. Sci Rep 4:6370. https:\/\/doi.org\/10.1038\/srep06370","journal-title":"Sci Rep"},{"issue":"Pt 4","key":"10736_CR17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/brain\/awl356","volume":"130","author":"A Krarup-Hansen","year":"2007","unstructured":"Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rorth M, Krarup C (2007) Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain 130(Pt 4):1076\u201388. https:\/\/doi.org\/10.1093\/brain\/awl356","journal-title":"Brain"},{"issue":"1-2","key":"10736_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pain.2004.01.021","volume":"109","author":"PM Dougherty","year":"2004","unstructured":"Dougherty PM, Cata JP, Cordella JV, Burton A, Weng HR (2004) Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109(1\u20132):132\u2013142","journal-title":"Pain"},{"issue":"2","key":"10736_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11060-015-2049-x","volume":"127","author":"M Saad","year":"2016","unstructured":"Saad M, Psimaras D, Tafani C, Sallansonnet-Froment M, Calvet JH, Vilier A et al (2016) Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy. J Neurooncol 127(2):373\u201380. https:\/\/doi.org\/10.1007\/s11060-015-2049-x","journal-title":"J Neurooncol"},{"issue":"1","key":"10736_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/ajp.0000000000000649","volume":"35","author":"C Miaskowski","year":"2019","unstructured":"Miaskowski C, Paul SM, Mastick J, Abrams G, Topp K, Smoot B et al (2019) Contribution of loss of large fiber function to pain in 2 samples of oncology patients. Clin J Pain 35(1):37\u201342. https:\/\/doi.org\/10.1097\/ajp.0000000000000649","journal-title":"Clin J Pain"},{"key":"10736_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/17448069231185694","volume":"19","author":"N Mansooralavi","year":"2023","unstructured":"Mansooralavi N, Khomula EV, Levine JD (2023) Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in Sprague Dawley rats. Mol Pain 19:17448069231185694. https:\/\/doi.org\/10.1177\/17448069231185694","journal-title":"Mol Pain"},{"issue":"6","key":"10736_CR22","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1152\/jn.1999.81.6.2753","volume":"81","author":"AB Vallbo","year":"1999","unstructured":"Vallbo AB, Olausson H, Wessberg J (1999) Unmyelinated afferents constitute a second system coding tactile stimuli of the human hairy skin. J Neurophysiol 81(6):2753\u201363. https:\/\/doi.org\/10.1152\/jn.1999.81.6.2753","journal-title":"J Neurophysiol"},{"issue":"5","key":"10736_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nn.2312","volume":"12","author":"LS L\u00f6ken","year":"2009","unstructured":"L\u00f6ken LS, Wessberg J, Morrison I, McGlone F, Olausson H (2009) Coding of pleasant touch by unmyelinated afferents in humans. Nat Neurosci 12(5):547\u2013548. https:\/\/doi.org\/10.1038\/nn.2312","journal-title":"Nat Neurosci"},{"issue":"3","key":"10736_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00221-009-2007-y","volume":"204","author":"I Morrison","year":"2010","unstructured":"Morrison I, L\u00f6ken LS, Olausson H (2010) The skin as a social organ. Exp Brain Res 204(3):305\u2013314. https:\/\/doi.org\/10.1007\/s00221-009-2007-y","journal-title":"Exp Brain Res"},{"issue":"7273","key":"10736_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature08505","volume":"462","author":"RP Seal","year":"2009","unstructured":"Seal RP, Wang X, Guan Y, Raja SN, Woodbury CJ, Basbaum AI et al (2009) Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors. Nature 462(7273):651\u20135. https:\/\/doi.org\/10.1038\/nature08505","journal-title":"Nature"},{"key":"10736_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.1066069","volume":"3","author":"C Meregalli","year":"2022","unstructured":"Meregalli C, Monza L, Jongen JLM (2022) A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain. Front Pain Res 3:1066069. https:\/\/doi.org\/10.3389\/fpain.2022.1066069","journal-title":"Front Pain Res"},{"issue":"2","key":"10736_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jpainsymman.2016.12.342","volume":"54","author":"C Miaskowski","year":"2017","unstructured":"Miaskowski C, Mastick J, Paul SM, Topp K, Smoot B, Abrams G et al (2017) Chemotherapy-induced neuropathy in cancer survivors. J Pain Symptom Manage 54(2):204\u201318 e2. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.12.342","journal-title":"J Pain Symptom Manage"},{"key":"10736_CR28","volume-title":"AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care","author":"TF Babor","year":"2001","unstructured":"Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001) AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. World Health Organization, Geneva, Switzerland"},{"key":"10736_CR29","volume-title":"Performance scale. Factors that influence the therapeutic response in cancer: a comprehensive treatise","author":"D Karnofsky","year":"1977","unstructured":"Karnofsky D (1977) Performance scale. Factors that influence the therapeutic response in cancer: a comprehensive treatise. Plenum Press, New York"},{"issue":"2","key":"10736_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/art.10993","volume":"49","author":"O Sangha","year":"2003","unstructured":"Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49(2):156\u2013163. https:\/\/doi.org\/10.1002\/art.10993","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10736_CR31","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/j.pain.0000000000000456","volume":"157","author":"V Posternak","year":"2016","unstructured":"Posternak V, Dunn LB, Dhruva A, Paul SM, Luce J, Mastick J et al (2016) Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain. Pain 157(4):892\u2013900. https:\/\/doi.org\/10.1097\/j.pain.0000000000000456","journal-title":"Pain"},{"issue":"6","key":"10736_CR32","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jpainsymman.2014.11.292","volume":"49","author":"DJ Langford","year":"2015","unstructured":"Langford DJ, Schmidt B, Levine JD, Abrams G, Elboim C, Esserman L et al (2015) Preoperative breast pain predicts persistent breast pain and disability after breast cancer surgery. J Pain Symptom Manage 49(6):981\u201394. https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.11.292","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10736_CR33","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/ard.37.4.378","volume":"37","author":"WW Downie","year":"1978","unstructured":"Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA (1978) Studies with pain rating scales. Ann Rheum Dis 37(4):378\u2013381","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10736_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jpain.2004.11.002","volume":"6","author":"MP Jensen","year":"2005","unstructured":"Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS (2005) Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 6(2):98\u2013106","journal-title":"J Pain"},{"issue":"11","key":"10736_CR35","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jpain.2006.04.003","volume":"7","author":"MP Jensen","year":"2006","unstructured":"Jensen MP, Gammaitoni AR, Olaleye DO, Oleka N, Nalamachu SR, Galer BS (2006) The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome. J Pain 7(11):823\u2013832. https:\/\/doi.org\/10.1016\/j.jpain.2006.04.003","journal-title":"J Pain"},{"key":"10736_CR36","unstructured":"Bell-Krotoski JA. Sensibility testing with the Semmes-Weinstein monofilaments. 5th ed. Rehabilitation of the hand and upper extremity. St Louis: Mosby, Inc.; 2002."},{"issue":"3","key":"10736_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5935\/0305-7518.19860028","volume":"57","author":"JA Birke","year":"1986","unstructured":"Birke JA, Sims DS (1986) Plantar sensory threshold in the ulcerative foot. Lepr Rev 57(3):261\u2013267. https:\/\/doi.org\/10.5935\/0305-7518.19860028","journal-title":"Lepr Rev"},{"issue":"3","key":"10736_CR38","first-page":"291","volume":"68","author":"JA Birke","year":"2000","unstructured":"Birke JA, Brandsma JW, Schreuders TA, Piefer A (2000) Sensory testing with monofilaments in Hansen\u2019s disease and normal control subjects. Int J Lepr Other Mycobact Dis 68(3):291\u2013298","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"1","key":"10736_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/hanthe.2002.v15.01548","volume":"15","author":"N Massy-Westropp","year":"2002","unstructured":"Massy-Westropp N (2002) The effects of normal human variability and hand activity on sensory testing with the full Semmes-Weinstein monofilaments kit. J Hand Ther 15(1):48\u201352","journal-title":"J Hand Ther"},{"issue":"5","key":"10736_CR40","first-page":"LC20","volume":"12","author":"AA Medakkel","year":"2018","unstructured":"Medakkel AA, Sheela P (2018) Vibration perception threshold values and clinical symptoms of diabetic peripheral neuropathy. J Clin Diagn Res 12(5):LC20\u2013LC23","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10736_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jdiacomp.2009.09.006","volume":"25","author":"N Papanas","year":"2011","unstructured":"Papanas N, Ziegler D (2011) New diagnostic tests for diabetic distal symmetric polyneuropathy. J Diabetes Complicat 25(1):44\u201351. https:\/\/doi.org\/10.1016\/j.jdiacomp.2009.09.006","journal-title":"J Diabetes Complicat"},{"issue":"923","key":"10736_CR42","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/pmj.78.923.541","volume":"78","author":"V Viswanathan","year":"2002","unstructured":"Viswanathan V, Snehalatha C, Seena R, Ramachandran A (2002) Early recognition of diabetic neuropathy: evaluation of a simple outpatient procedure using thermal perception. Postgrad Med J 78(923):541\u2013542. https:\/\/doi.org\/10.1136\/pmj.78.923.541","journal-title":"Postgrad Med J"},{"issue":"6","key":"10736_CR43","first-page":"387","volume":"67","author":"S Mathias","year":"1986","unstructured":"Mathias S, Nayak US, Isaacs B (1986) Balance in elderly patients: the \u201cget-up and go\u201d test. Arch Phys Med Rehabil 67(6):387\u2013389","journal-title":"Arch Phys Med Rehabil"},{"issue":"12","key":"10736_CR44","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.apmr.2008.05.020","volume":"89","author":"D Hernandez","year":"2008","unstructured":"Hernandez D, Rose DJ (2008) Predicting which older adults will or will not fall using the Fullerton Advanced Balance scale. Arch Phys Med Rehabil 89(12):2309\u20132315. https:\/\/doi.org\/10.1016\/j.apmr.2008.05.020","journal-title":"Arch Phys Med Rehabil"},{"issue":"11","key":"10736_CR45","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.apmr.2006.07.263","volume":"87","author":"DJ Rose","year":"2006","unstructured":"Rose DJ, Lucchese N, Wiersma LD (2006) Development of a multidimensional balance scale for use with functionally independent older adults. Arch Phys Med Rehabil 87(11):1478\u20131485. https:\/\/doi.org\/10.1016\/j.apmr.2006.07.263","journal-title":"Arch Phys Med Rehabil"},{"key":"10736_CR46","unstructured":"Muthen LK, Muthen BO (1998\u20132020) Mplus User\u2019s Guide (8th ed.), 8th ed. Muthen & Muthen, Los Angeles, CA"},{"issue":"4","key":"10736_CR47","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/10705510701575396","volume":"14","author":"KL Nylund","year":"2007","unstructured":"Nylund KL, Asparoutiov T, Muth\u00e9n BO (2007) Deciding on the number of classes in latent class analysis and growth mixture modeling:: A Monte Carlo simulation study. Struct Equ Modeling 14(4):535\u201369. https:\/\/doi.org\/10.1080\/10705510701575396","journal-title":"Struct Equ Modeling"},{"issue":"2","key":"10736_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.0006-341x.1999.00463.x","volume":"55","author":"B Muthen","year":"1999","unstructured":"Muthen B, Shedden K (1999) Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics 55(2):463\u2013469. https:\/\/doi.org\/10.1111\/j.0006-341x.1999.00463.x","journal-title":"Biometrics"},{"issue":"6","key":"10736_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1312","volume":"9","author":"A Molassiotis","year":"2019","unstructured":"Molassiotis A, Cheng HL, Leung KT, Li YC, Wong KH, Au JSK et al (2019) Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy. Brain Behav 9(6):e01312. https:\/\/doi.org\/10.1002\/brb3.1312","journal-title":"Brain Behav"},{"issue":"2","key":"10736_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10549-021-06304-6","volume":"189","author":"IR Kleckner","year":"2021","unstructured":"Kleckner IR, Jusko TA, Culakova E, Chung K, Kleckner AS, Asare M et al (2021) Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy. Breast Cancer Res Treat 189(2):521\u201332. https:\/\/doi.org\/10.1007\/s10549-021-06304-6","journal-title":"Breast Cancer Res Treat"},{"key":"10736_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2025.104457","volume":"81","author":"H Xu","year":"2025","unstructured":"Xu H, Li H, Fan Y, Wang Y, Li Z, Zhou L et al (2025) Analysis of factors influencing chemotherapy-induced peripheral neuropathy in breast cancer patients using a random forest model. Breast 81:104457. https:\/\/doi.org\/10.1016\/j.breast.2025.104457","journal-title":"Breast"},{"key":"10736_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/628670","volume":"2011","author":"X He","year":"2011","unstructured":"He X, Clarke SJ, McLachlan AJ (2011) Clinical pharmacology of chemotherapy agents in older people with cancer. Curr Gerontol Geriatr Res 2011:628670. https:\/\/doi.org\/10.1155\/2011\/628670","journal-title":"Curr Gerontol Geriatr Res"},{"issue":"8","key":"10736_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/jjco\/28.8.463","volume":"28","author":"I Sekine","year":"1998","unstructured":"Sekine I, Fukuda H, Kunitoh H, Saijo N (1998) Cancer chemotherapy in the elderly. Jpn J Clin Oncol 28(8):463\u2013473. https:\/\/doi.org\/10.1093\/jjco\/28.8.463","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10736_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/107327480701400105","volume":"14","author":"A Hurria","year":"2007","unstructured":"Hurria A, Lichtman SM (2007) Pharmacokinetics of chemotherapy in the older patient. Cancer Control 14(1):32\u201343","journal-title":"Cancer Control"},{"issue":"9","key":"10736_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70929","volume":"14","author":"S Abraham","year":"2025","unstructured":"Abraham S, Parekh J, Lee S, Afrin H, Rozenblit M, Blenman KRM et al (2025) Accelerated aging in cancer and cancer treatment: current status of biomarkers. Cancer Med 14(9):e70929. https:\/\/doi.org\/10.1002\/cam4.70929","journal-title":"Cancer Med"},{"key":"10736_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063319","author":"S Wang","year":"2024","unstructured":"Wang S, El Jurdi N, Thyagarajan B, Prizment A, Blaes AH (2024) Accelerated aging in cancer survivors: cellular senescence, frailty, and possible opportunities for interventions. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25063319","journal-title":"Int J Mol Sci"},{"key":"10736_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf036","author":"MS von Itzstein","year":"2025","unstructured":"von Itzstein MS, Rashdan S, Dahlberg SE, Gerber DE, Sandler AB, Schiller JH et al (2025) Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancer. Oncologist. https:\/\/doi.org\/10.1093\/oncolo\/oyaf036","journal-title":"Oncologist"},{"issue":"7","key":"10736_CR58","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14829","volume":"30","author":"Y Cao","year":"2024","unstructured":"Cao Y, Jiang W, Yan F, Pan Y, Gei L, Lu S et al (2024) Sex differences in PD-L1-induced analgesia in paclitaxel-induced peripheral neuropathy mice depend on TRPV1-based inhibition of CGRP. CNS Neurosci Ther 30(7):e14829. https:\/\/doi.org\/10.1111\/cns.14829","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10736_CR59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1523\/jneurosci.1691-21.2021","volume":"42","author":"L Staurengo-Ferrari","year":"2022","unstructured":"Staurengo-Ferrari L, Bonet IJM, Araldi D, Green PG, Levine JD (2022) Neuroendocrine stress axis-dependence of duloxetine analgesia (anti-hyperalgesia) in chemotherapy-induced peripheral neuropathy. J Neurosci 42(3):405\u2013415. https:\/\/doi.org\/10.1523\/jneurosci.1691-21.2021","journal-title":"J Neurosci"},{"issue":"3","key":"10736_CR60","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/j.pain.0000000000002073","volume":"162","author":"L Staurengo-Ferrari","year":"2021","unstructured":"Staurengo-Ferrari L, Green PG, Araldi D, Ferrari LF, Miaskowski C, Levine JD (2021) Sexual dimorphism in the contribution of neuroendocrine stress axes to oxaliplatin-induced painful peripheral neuropathy. Pain 162(3):907\u2013918. https:\/\/doi.org\/10.1097\/j.pain.0000000000002073","journal-title":"Pain"},{"key":"10736_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100152","volume":"4","author":"HT Rakshith","year":"2023","unstructured":"Rakshith HT, Lohita S, Rebello AP, Goudanavar PS, Raghavendra Naveen N (2023) Sex differences in drug effects and\/or toxicity in oncology. Curr Res Pharmacol Drug Discov 4:100152. https:\/\/doi.org\/10.1016\/j.crphar.2022.100152","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"10736_CR62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/B978-0-444-53630-3.00009-9","volume":"186","author":"JS Mogil","year":"2010","unstructured":"Mogil JS, Bailey AL (2010) Sex and gender differences in pain and analgesia. Prog Brain Res 186:141\u201357. https:\/\/doi.org\/10.1016\/B978-0-444-53630-3.00009-9","journal-title":"Prog Brain Res"},{"issue":"5","key":"10736_CR63","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.21873\/anticanres.17587","volume":"45","author":"D Rades","year":"2025","unstructured":"Rades D, Bartscht T, Rody A, Yu NY, Ballegaard M (2025) Chemotherapy-induced moderate to severe peripheral neuropathy in patients receiving adjuvant radiotherapy for breast cancer. Anticancer Res 45(5):2123\u20132135. https:\/\/doi.org\/10.21873\/anticanres.17587","journal-title":"Anticancer Res"},{"key":"10736_CR64","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences, 2 nd ed. Lawrence Erlbaum Associates, Hillsdale, NJ","edition":"2 nd ed"},{"issue":"4","key":"10736_CR65","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4065\/77.4.371","volume":"77","author":"GH Guyatt","year":"2002","unstructured":"Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Clinical Significance Consensus Meeting G (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77(4):371\u201383. https:\/\/doi.org\/10.4065\/77.4.371","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10736_CR66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139\u2013144","journal-title":"J Clin Oncol"},{"issue":"5","key":"10736_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-00903-0","volume":"22","author":"CS Tofthagen","year":"2020","unstructured":"Tofthagen CS, Cheville AL, Loprinzi CL (2020) The physical consequences of chemotherapy-induced peripheral neuropathy. Curr Oncol Rep 22(5):50. https:\/\/doi.org\/10.1007\/s11912-020-00903-0","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"10736_CR68","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jshs.2018.09.010","volume":"8","author":"L Li","year":"2019","unstructured":"Li L, Zhang S, Dobson J (2019) The contribution of small and large sensory afferents to postural control in patients with peripheral neuropathy. J Sport Health Sci 8(3):218\u2013227. https:\/\/doi.org\/10.1016\/j.jshs.2018.09.010","journal-title":"J Sport Health Sci"},{"issue":"22","key":"10736_CR69","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1002\/cam4.4328","volume":"10","author":"MR Trendowski","year":"2021","unstructured":"Trendowski MR, Lusk CM, Ruterbusch JJ, Seaton R, Simon MS, Greenwald MK et al (2021) Chemotherapy-induced peripheral neuropathy in African American cancer survivors: risk factors and quality of life outcomes. Cancer Med 10(22):8151\u201361. https:\/\/doi.org\/10.1002\/cam4.4328","journal-title":"Cancer Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10736-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10736-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10736-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:29:45Z","timestamp":1781058585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10736-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10736"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10736-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.\u00a0Approval was granted by the Committee on Human Research at the University of\u00a0California, San Francisco and the Institutional Review Board at each of the study sites.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"513"}}